ANI Pharmaceuticals, Inc. (ANIP) is a publicly traded Healthcare sector company. As of May 21, 2026, ANIP trades at $81.97 with a market cap of $1.80B and a P/E ratio of 19.96. ANIP moved +2.07% today. Year to date, ANIP is +4.25%; over the trailing twelve months it is +35.22%. Its 52-week range spans $52.50 to $99.50. Analyst consensus is strong buy with an average price target of $115.20. Rallies surfaces ANIP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ANI Pharmaceuticals, Inc. (ANIP) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ANIP moved +2.07% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $81.97 |
| Market Cap | $1.80B |
| P/E Ratio | 19.96 |
| EPS | $4.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $99.50 |
| 52-Week Low | $52.50 |
| Volume | 287.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $923.71M |
| Net Income | $92.15M |
| Gross Margin | 0.00% |
7 analysts cover ANIP: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $115.20.